The surgical anesthesia drug, propofol, used in tumor removal, could help promote the spread of cancer by triggering changes in tumor cell properties.
The surgical anesthesia drug, propofol, used in tumor removal, could help promote the spread of cancer by triggering changes in tumor cell properties.
Researchers find the sweet spot between strength and biocompatibility in these tiny cell-carrying microrobots.
Engineers and oncologists teamed up to develop a microfluidic chip capable of capturing the body’s natural killer immune cells to harvest their cancer-killing exosomes.
A small trial indicates that Moderna’s experimental SARS-CoV-2 vaccine is effective and safe in older adults, a population group most vulnerable to severe COVID-19.
Zwitterionic polymers allow researchers to fabricate drug-carrying microrobots that can operate covertly under the immune system’s radar.
Scientists express cautious optimism about two potential COVID-19 vaccine candidates from the UK and China.
A new in vitro model of the body’s immune system better predicts its response to new therapeutics, potentially lowering the high costs and low success rates of drug discovery.
The interaction between the innate and the adaptive immune responses to COVID-19 may be impacting disease progression, and the answer might be to suppress them.
A collaborative team of German scientists identify which lung cells are susceptible to SARS-CoV-2 and why infection severity varies in different demographics.
Researchers have mapped the immune response of one of Australia’s first COVID-19 patients.